Skip to main content

Month: May 2020

NKT A/S søger at styrke sit kapitalgrundlag

Selskabsmeddelelse13. maj 2020Meddelelse nr. 8  MÅ IKKE UDLEVERES, OFFENTLIGGØRES ELLER DISTRIBUERES, HVERKEN HELT ELLER DELVIST, DIREKTE ELLER INDIREKTE, I USA, CANADA, AUSTRALIEN, JAPAN ELLER SYDAFRIKA ELLER I NOGEN ANDEN JURISDIKTION, HVOR UDLEVERING, OFFENTLIGGØRELSE ELLER DISTRIBUTION VILLE VÆRE ULOVLIGT.NKT A/S søger at styrke sit kapitalgrundlagBestyrelsen (Bestyrelsen) for NKT A/S (NKT eller Selskabet) har besluttet at søge at styrke Selskabets kapitalgrundlag. Beslutningen følger iværksættelse af en analyse af kapitalstrukturen, jf. Selskabsmeddelelse nr. 6 af 5. maj 2020.Bestyrelsen har afsluttet analysen og søger nu at styrke Selskabets finansielle stilling baseret på følgende:            Behov for at styrke det økonomiske fundament for at kunne eksekvere på højspændingsordrebogen og på positive markedsudsigter med stadig mere...

Continue reading

Virbac to divest U.S. Rights to SENTINEL® brands to MSD Animal Health

Virbac announces that it has entered into an agreement with MSD Animal Health, a division of Merck & Co., Inc., Kenilworth, N.J., USA (NYSE:MRK), to divest veterinary products currently marketed in the United States under the SENTINEL® brands by Virbac, for US $400 million in an all-cash deal subject to customary post-closing adjustments. These assets were acquired in early 2015 from Eli Lilly.Under the terms of this agreement, Virbac will divest a combination of titles and rights for the United States on trademarks, marketing authorizations, patents, know-how, and other assets, related to two parasiticides for dogs: SENTINEL® FLAVOR TABS® and SENTINEL®  SPECTRUM®. In relation with the transaction, Virbac will keep its commercial structure substantially unchanged, and will continue to manufacture SENTINEL® SPECTRUM® at its Bridgeton,...

Continue reading

Virbac prêt à céder les droits américains des marques SENTINEL® à MSD Santé Animale

Virbac annonce la signature d’un accord avec MSD Santé Animale, une division de Merck & Co., Inc., Kenilworth, N.J., USA (NYSE:MRK), en vue de la cession de produits vétérinaires, actuellement commercialisés par Virbac aux États-Unis sous la marque SENTINEL®, pour un prix total de 400 millions US$ en numéraire, et sous réserve des ajustements post-clôture usuels pour ce type d’opération. Ces actifs avaient été acquis début 2015 auprès d’Eli Lilly.Les termes de cet accord prévoient la cession par Virbac d’un ensemble de droits pour les États-Unis sur les marques, autorisations de mise sur le marché, brevets, savoir-faire, et autres actifs, relatifs à deux antiparasitaires pour chiens : SENTINEL® FLAVOR TABS® et SENTINEL® SPECTRUM®. Dans le cadre de cette transaction, Virbac conservera sa structure commerciale quasiment inchangée et...

Continue reading

NKT A/S to issue up to 4,951,106 new shares in a directed issue and private placement

Company Announcement13 May 2020Announcement No. 9NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.NKT A/S to issue up to 4,951,106 new shares in a directed issue and private placementThe Board of Directors of NKT A/S (NKT or the Company) has resolved to launch an offering of new shares at market price (the Offering). The Offering will be completed through an accelerated book-building process and will consist of up to 4,951,106 new shares (the New Shares), representing up to 18.15 % of NKT’s currently registered share capital in a private placement directed at institutional and professional investors in Denmark and certain...

Continue reading

NKT A/S udsteder op til 4.951.106 nye aktier i forbindelse med rettet emission og privatplacering

Selskabsmeddelelse13. maj 2020Meddelelse nr. 9MÅ IKKE UDLEVERES, OFFENTLIGGØRES ELLER DISTRIBUERES, HVERKEN HELT ELLER DELVIST, DIREKTE ELLER INDIREKTE, I USA, CANADA, AUSTRALIEN, JAPAN ELLER SYDAFRIKA ELLER I NOGEN ANDEN JURISDIKTION, HVOR UDLEVERING, OFFENTLIGGØRELSE ELLER DISTRIBUTION VILLE VÆRE ULOVLIGT.NKT A/S udsteder op til 4.951.106 nye aktier i forbindelse med rettet emission og privatplaceringBaggrund for UdbuddetDen 13. maj 2020 offentliggjorde NKT selskabets plan for at styrke dets kapitalgrundlag, jf. Selskabsmeddelelse nr. 8. Udbuddet er det første trin i gennemførelsen af denne kapitalplan, og nettoprovenuet fra Udbuddet vil blive anvendt til at styrke NKT’s kapitalgrundlag som oplyst i nævnte selskabsmeddelelse.

Continue reading

NKT A/S Q1 2020: Improved financial results driven by the power cable business

Company Announcement13 May 2020Announcement No. 7NKT A/S Q1 2020: Improved financial results driven by the power cable businessNKT CEO Alexander Kara says:– I am satisfied to see revenue and earnings increase in Q1 2020 based on positive development in all three business lines. I am also very pleased that in May we booked our largest high-voltage DC order ever, getting a major part of theSuedOstLink project which underlines our position as a key partner in the green transformation of Germany. NKT Photonics recorded lower revenue and earnings in Q1 2020 as performance was negatively impacted by the coronavirus pandemic.Q1 2020 financial highlights:*std. metal prices2020 financial outlookThe financial outlook for NKT is unchanged from Company Announcement No. 6 of 5 May 2020. The revenue (std. metal prices) is still expected to be...

Continue reading

NKT A/S 1. kvartal 2020:  Forbedrede finansielle resultater drevet af kabelforretningen

Selskabsmeddelelse13. maj 2020Meddelelse nr. 7NKT A/S 1. kvartal 2020:  Forbedrede finansielle resultater drevet af kabelforretningenNKT CEO Alexander Kara siger:– Jeg er tilfreds med at omsætning og indtjening steg i 1. kvartal 2020, og at udviklingen var drevet af alle tre forretningsområder. Jeg er også meget glad for, at vi tidligere i maj vandt den største DC højspændingsordre nogensinde i form af en væsentlig del af projektet SuedOstLink, som understreger vores position som en central aktør i den grønne transformation i Tyskland. NKT Photonics leverede lavere indtjening og omsætning i 1. kvartal 2020 og var negativt påvirket af coronavirus pandemien. *std. metalpriserFinansielle forventninger til 2020 De finansielle forventninger til NKT er uændrede i forhold til Selskabsmeddelelse nr. 6 af 5. maj 2020. Omsætningen (std. metalpriser)...

Continue reading

Lyft Announces Pricing of Offering of $650 million of Convertible Senior Notes and Capped Call to Increase Effective Conversion Price to $73.83 (150% Effective Conversion Premium)

SAN FRANCISCO, May 12, 2020 (GLOBE NEWSWIRE) — Lyft, Inc. (“Lyft”) (NASDAQ:LYFT) today announced the pricing of $650 million aggregate principal amount of Convertible Senior Notes due 2025 (the “notes”) in a private offering (the “offering”) to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). Lyft also granted the initial purchasers of the notes a 13-day option to purchase up to an additional $97.5 million aggregate principal amount of the notes. The sale of the notes to the initial purchasers is expected to settle on May 15, 2020, subject to customary closing conditions, and is expected to result in approximately $637.5 million in net proceeds to Lyft after deducting the initial purchasers’ discount and estimated offering expenses...

Continue reading

Bekaert: First quarter trading update 2020

Strong Q1 performance positions Bekaert well to confront the crisisSafe working conditions – customer centricity – strong cash liquidity HighlightsComprehensive measures to safeguard employees, with a limited number of Covid-19 infectionsSales down -11% due to government-mandated lockdowns and global tire & automotive demand declineEffective cost reduction measures in placeLiquidity more than  € 190 million up on year-end 2019 to over € 750 million cash on handDebt leverage stable from year-end 2019 at 2.1x underlying EBITDAGross dividend proposal of € 0.35 with payment postponed to 20 November 2020OutlookWe project Q2 sales to markedly decline in different sectors that are relevant to us. While the magnitude of the impact of the Covid-19 pandemic on the global economy has become visible, its duration remains highly uncertain. We...

Continue reading

Bekaert: Activiteitenverslag eerste kwartaal 2020

Sterke prestatie 1ste kwartaal brengt Bekaert in stelling om crisis aan te pakkenVeilige werkomstandigheden – klantgerichtheid – sterke cashliquiditeit HoofdpuntenUitgebreide maatregelen om medewerkers te beschermen; beperkt aantal Covid-19-besmettingenOmzet -11% lager door opgelegde lockdowns door overheden en daling van de vraag in de banden- en automobielsector wereldwijdEffectieve kostenbesparingsmaatregelen van krachtLiquiditeit meer dan € 190 miljoen hoger dan bij jaareinde 2019, met meer dan € 750 miljoen cash onmiddellijk ter beschikkingStabiele schuldgraad tegenover jaareinde 2019 aan 2,1 keer de onderliggende EBITDABrutodividendvoorstel van € 0,35 met uitstel uitbetaling tot 20 november 2020VooruitzichtenWe verwachten dat de omzet in het tweede kwartaal aanzienlijk zal zakken in verschillende sectoren die relevant zijn voor...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.